Zota Healthcare
1,522.60
-15.80(-1.03%)
Market Cap₹4,616.20 Cr
PE Ratio-79.93
IndustryHealthcare
Company Performance:
1D-1.03%
1M+4.47%
6M+72.36%
1Y+145.96%
5Y+974.14%
View Company Insightsright
More news about Zota Healthcare
18Mar 25
Zota Health Care Expands Reach: Secures Product Registration in Cambodia
Zota Health Care has obtained a product registration license in Cambodia for Azitoz 500, valid for five years. This milestone enables the company to enter the Cambodian pharmaceutical market, potentially increasing sales and market share in Southeast Asia. The extended license period allows Zota Health Care to invest in marketing, distribution, and possible local partnerships, setting a precedent for future international expansion efforts.
17Mar 25
Zota Health Care Expands Reach: Secures Product Registration in Cambodia
Zota Health Care has obtained a five-year product registration license in Cambodia for its medication Azitoz 500. This approval marks a significant step in the company's international expansion strategy, opening up opportunities in the Cambodian pharmaceutical market. The registration validates the product's quality and efficacy, potentially contributing to Zota Health Care's revenue growth and market presence in Southeast Asia.
Zota Healthcare
1,522.60
-15.80
(-1.03%)
1 Year Returns:+145.96%
Industry Peers
Sun Pharmaceutical
1,679.10
(+1.21%)
Divis Laboratories
6,621.50
(+0.32%)
Cipla
1,577.60
(+0.52%)
Torrent Pharmaceuticals
3,584.30
(+1.43%)
Dr Reddys Laboratories
1,255.90
(+1.27%)
Mankind Pharma
2,476.60
(+0.87%)
Zydus Life Science
987.65
(+0.31%)
Lupin
1,940.00
(-0.57%)
Alkem Laboratories
5,581.50
(+1.04%)
Aurobindo Pharma
1,101.00
(-0.48%)